Durvalumab and tremelimumab for hepatocellular carcinoma in patients listed for a liver transplant.

被引：0
|
作者：
Sohal, Davendra
Moreland, Katie
Quillin, Ralph
Lemon, Kristina
Rojan, Adam
Olowokure, Olugbenga Olanrele
Shah, Shimul
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS638
引用
收藏
页码：TPS638 / TPS638
页数：1
相关论文
共 50 条
  • [1] Durvalumab and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
    Ryan, Carrie E.
    Lambdin, Jacob
    Shah, Shimul
    Quillin, Ralph Cutler
    Lemon, Kristina
    Hernandez, Jonathan M.
    Sohal, Davendra
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 686 - 687
  • [2] Durvalumab and tremelimumab for hepatocellular carcinoma in patients listed for a liver transplant
    Sohal, Davendra
    Abouelezz, Khaled Fahmy
    Moreland, Katie
    Quillin, Ralph
    Lemon, Kristina
    Rojan, Adam
    Olowokure, Olugbenga Olanrele
    Kord, Ali
    Shah, Shimul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Durvalumab and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
    Carrie E. Ryan
    Jacob Lambdin
    Shimul Shah
    Ralph Cutler Quillin
    Kristina Lemon
    Jonathan M. Hernandez
    Davendra Sohal
    [J]. Annals of Surgical Oncology, 2023, 30 : 686 - 687
  • [4] Statin Underutilization in Patients Listed for Liver Transplant.
    Mishra, K.
    Naffouj, S.
    Modi, S.
    Dagher, C.
    Gorgis, S.
    Venkat, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 714 - 714
  • [5] Durvalumab plus tremelimumab in unresectable hepatocellular carcinoma
    Kudo, Masatoshi
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (04) : 592 - 596
  • [6] Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma
    Tamaki, Nobuharu
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Tada, Toshifumi
    Nakamura, Shinichiro
    Ochi, Hironori
    Mashiba, Toshie
    Doisaki, Masao
    Marusawa, Hiroyuki
    Kobashi, Haruhiko
    Fujii, Hideki
    Ogawa, Chikara
    Nonogi, Michiko
    Arai, Hirotaka
    Uchida, Yasushi
    Urawa, Naohito
    Narita, Ryoichi
    Akahane, Takehiro
    Kondo, Masahiko
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Izumi, Namiki
    Kurosaki, Masayuki
    [J]. ANTICANCER RESEARCH, 2024, 44 (09) : 3913 - 3918
  • [7] Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma
    de Castria, Tiago Biachi
    Khalil, Danny N.
    Harding, James J.
    O'Reilly, Eileen M.
    Abou-Alfa, Ghassan K.
    [J]. FUTURE ONCOLOGY, 2022, 18 (33) : 3769 - 3782
  • [8] COST-EFFECTIVENESS OF TREMELIMUMAB OR TREMELIMUMAB IN COMBINATION WITH DURVALUMAB VS DURVALUMAB AS TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA
    Tang, T.
    Shi, L.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S138 - S138
  • [9] Myositis and myocarditis with tremelimumab and durvalumab combination therapy for hepatocellular carcinoma
    Lopez, Thais Lizondo
    Mendez, Iria Carro
    Martin, Esther Carcelero San
    [J]. MEDICINA CLINICA, 2024, 162 (07): : 358 - 359
  • [10] Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)
    Abou-Alfa, Ghassan K.
    Lau, George
    Kudo, Masatoshi
    Chan, Stephen L.
    Kelley, Robin Kate
    Furuse, Junji
    Sukeepaisarnjaroen, Wattana
    Kang, Yoon Koo
    Dao, Tu Van
    De Toni, Enrico N.
    Rimassa, Lorenza
    Breder, Valeriy
    Vasilyev, Alexander
    Heurgue, Alexandra
    Tam, Vincent C.
    Mody, Kabir
    Thungappa, Satheesh Chiradoni
    Ostapenko, Yurii
    Yau, Thomas
    Azevedo, Sergio
    Varela, Maria
    Cheng, Ann-Lii
    Qin, Shukui
    Galle, Peter R.
    Ali, Sajid
    Gupta, Charu
    Makowsky, Mallory
    Kurland, John F.
    Negro, Alejandra
    Sangro, Bruno
    [J]. FUTURE ONCOLOGY, 2023, 19 (38) : 2505 - 2516
12345